| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/01/2009 | CN101396408A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396407A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396406A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396405A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396404A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396403A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396402A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396401A Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396400A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396399A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396398A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396397A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396396A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396395A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396394A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396393A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396392A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396391A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396390A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396381A Valerian extract and preparation method and use thereof |
| 04/01/2009 | CN101396380A Huperzia serrata extract and preparation method thereof |
| 04/01/2009 | CN101396372A Use of C60 polyhydroxy derivates in preventing and treating related disease of mitochondria damage |
| 04/01/2009 | CN101396371A Quality control method of Tibet crude-medicine processing material and new use thereof |
| 04/01/2009 | CN101396365A Uses of 2-[piperidinyl] methyl-2, 3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one |
| 04/01/2009 | CN101396364A Zaleplon oral-cavity administration system or composition and preparation method thereof |
| 04/01/2009 | CN101396362A Use of benzhexol hydrochloride in withdrawal and treatment of opium poison |
| 04/01/2009 | CN101396358A Oxiracetam injection |
| 04/01/2009 | CN101396355A Use of bilobalide B in preparing medicine for promoting nerve cell regenerate |
| 04/01/2009 | CN101396353A Use of baclofen in withdrawal treatment of opium drug |
| 04/01/2009 | CN101396334A Curcumin lipid carrier and preparation method thereof |
| 04/01/2009 | CN101396125A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396124A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396123A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN101396116A Medicine composition for preventing the birth defect and improving the memory |
| 04/01/2009 | CN100473413C Chinese medicine preparation for treating senile dementia |
| 04/01/2009 | CN100473387C Calf serum de-protein injection and producing method thereof |
| 04/01/2009 | CN100473381C Use of epothilones in the treatment of brain diseases associated with proliferative processes |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511074 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511053 Spiroazacyclic compounds as monoamine receptor modulators |
| 03/31/2009 | US7511049 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; anticarcinogenic, antiinflammatory, neurodegenerative agent, viricide; breast canceer, arthritis, Alzheimer's disease, cardiovascular diseases, with other active compounds |
| 03/31/2009 | US7511033 Dihydro-benzo[B][1,4]diazepin-2-one sulfonamide derivatives |
| 03/31/2009 | US7511026 Therapeutic agent for nerve damage |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510843 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | US7510702 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 03/31/2009 | CA2448602C Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2396734C Extraction of flavonoids |
| 03/31/2009 | CA2366256C Tropane analogs and methods for inhibition of monoamine transport |
| 03/31/2009 | CA2328368C Anti-inflammatory agents |
| 03/31/2009 | CA2226894C 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 03/31/2009 | CA2193627C Subcutaneous implant |
| 03/29/2009 | CA2704064A1 Humanized antibodies against the .beta.-amyloid peptide |
| 03/26/2009 | WO2009039461A2 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/26/2009 | WO2009039460A2 Co-administration of pimavanserin with other agents |
| 03/26/2009 | WO2009039362A2 Chiral synthesis of diazepinoquinolines |
| 03/26/2009 | WO2009039328A1 Pyridyl sulfonamides as modulators of ion channels |
| 03/26/2009 | WO2009039266A1 Methods of increasing sarcosine levels for treating schizophrenia |
| 03/26/2009 | WO2009038913A2 Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis |
| 03/26/2009 | WO2009038879A2 Stem cell differentiating agents and uses therefor |
| 03/26/2009 | WO2009038683A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/26/2009 | WO2009038514A1 A system and method to improve sensory function |
| 03/26/2009 | WO2009038204A1 Novel long-chain fatty acid derivative compound and g-protein-coupled receptor agonist containing the compound as active ingredient |
| 03/26/2009 | WO2009038112A1 Solid preparation comprising npyy5 receptor antagonist |
| 03/26/2009 | WO2009038110A1 Agent having neurotrophic factor-like activity |
| 03/26/2009 | WO2009038106A1 Oral administration drug containing alanyltyrosine |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009038012A1 Heterocyclic compound |
| 03/26/2009 | WO2009037707A2 N-phenyl anthranilic acid derivatives and uses thereof |
| 03/26/2009 | WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | WO2009037302A1 5-substituted-1, 4-benz0diazepines as phosphodiesterase inhibitors |
| 03/26/2009 | WO2009037296A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037294A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037293A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037247A1 Pyrazine derivatives and their use as potassium channel modulators |
| 03/26/2009 | WO2009037220A1 Tricyclic heterocyclic derivatives |
| 03/26/2009 | WO2009036955A1 Naphtyl-substituted sulfonamides |
| 03/26/2009 | WO2009036938A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products |
| 03/26/2009 | WO2009036766A1 Cyanoisoquinoline |
| 03/26/2009 | WO2009036754A1 Inhibitors of the myelin-associated glycoprotein (mag) |
| 03/26/2009 | WO2009036590A1 Compounds isolated from antrodia cinnamomea and use thereof |
| 03/26/2009 | WO2009016564A3 2-aza-bicyclo[3.3.0]octane derivatives |
| 03/26/2009 | WO2009016560A3 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 03/26/2009 | WO2009011901A3 Methods for promoting wakefulness |
| 03/26/2009 | WO2009009768A3 METHODS OF INHIBITING THE FORMATION OF AMYLOID-β DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 03/26/2009 | WO2009007457A3 Compounds and methods for modulating rho gtpases |
| 03/26/2009 | WO2008145838A3 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas |
| 03/26/2009 | WO2008116641A3 Oleyl phosphocholine |
| 03/26/2009 | WO2008058269A3 Compounds and methods for modulating protein trafficking |
| 03/26/2009 | WO2008032204A8 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 03/26/2009 | WO2008007211A8 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 03/26/2009 | WO2005044802A3 Tetrahydro-quinolinylurea derivatives as vrl antagonists |
| 03/26/2009 | US20090082471 Deuterium-enriched fingolimod |